Skip to main content
Signal8

Hooftman Leon

SEC insider (Form 3/4/5 filer). CIK 0002027157. Chief Medical Officer at Barinthus Biotherapeutics plc. (BRNS). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 9, 2026. Located in GERMANTOWN, MD.

Companies Hooftman Leon has filed insider reports for

  • Barinthus Biotherapeutics plc. (BRNS): Officer, Chief Medical Officer
Hooftman Leon profile photo

Hooftman Leon

CIK: 0002027157

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Barinthus Biotherapeutics plc. logo
BRNS

Barinthus Biotherapeutics plc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Barinthus Biotherapeutics plc. logo
    BRNS

    Barinthus Biotherapeutics plc.

    Sep 9, 2026
    Award
    Direct
    361.5K shares-
  • Barinthus Biotherapeutics plc. logo
    BRNS

    Barinthus Biotherapeutics plc.

    Sep 9, 2026
    Disposition
    Direct
    361.5K shares-
  • Barinthus Biotherapeutics plc. logo
    BRNS

    Barinthus Biotherapeutics plc.

    Feb 3, 2025
    Award

    Share Option (Right to Buy)

    Direct
    140K shares-

1-3 of 3